↓ Skip to main content

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

Overview of attention for article published in BMC Cancer, April 2005
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
123 Dimensions

Readers on

mendeley
82 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes
Published in
BMC Cancer, April 2005
DOI 10.1186/1471-2407-5-44
Pubmed ID
Authors

Pilar Zambrano, Blanca Segura-Pacheco, Enrique Perez-Cardenas, Lucely Cetina, Alma Revilla-Vazquez, Lucía Taja-Chayeb, Alma Chavez-Blanco, Enrique Angeles, Gustavo Cabrera, Karina Sandoval, Catalina Trejo-Becerril, Jose Chanona-Vilchis, Alfonso Duenas-González

Mendeley readers

The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 81 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 26%
Student > Ph. D. Student 14 17%
Student > Master 11 13%
Student > Doctoral Student 7 9%
Student > Postgraduate 6 7%
Other 14 17%
Unknown 9 11%
Readers by discipline Count As %
Medicine and Dentistry 24 29%
Agricultural and Biological Sciences 18 22%
Biochemistry, Genetics and Molecular Biology 17 21%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Immunology and Microbiology 3 4%
Other 7 9%
Unknown 10 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2021.
All research outputs
#6,808,622
of 20,991,427 outputs
Outputs from BMC Cancer
#1,856
of 7,530 outputs
Outputs of similar age
#109,230
of 282,917 outputs
Outputs of similar age from BMC Cancer
#1
of 1 outputs
Altmetric has tracked 20,991,427 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,530 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,917 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them